Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Biosimilar Insulin market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biosimilar Insulin market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilar Insulin industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Samsung Bioepis
Biogenomics
Geropharm
Eli Lilly
Gan&Lee Pharmaceuticals
Teva Pharmaceuticals
Paras Biopharmaceuticals
Julphar Gulf Pharmaceutical Industries
Sedico
Pfizer
Wockhardt
By Type:
Rapid Acting Insulins
Short Acting Insulins
Intermediate Insulins
Long Lasting Insulins
By End-User:
Hospital
Clinic
Medical Center
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilar Insulin Market
-
1.3 Market Segment by Type
-
1.3.1 China Biosimilar Insulin Market Size and Growth Rate of Rapid Acting Insulins from 2016 to 2027
-
1.3.2 China Biosimilar Insulin Market Size and Growth Rate of Short Acting Insulins from 2016 to 2027
-
1.3.3 China Biosimilar Insulin Market Size and Growth Rate of Intermediate Insulins from 2016 to 2027
-
1.3.4 China Biosimilar Insulin Market Size and Growth Rate of Long Lasting Insulins from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Biosimilar Insulin Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Biosimilar Insulin Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 China Biosimilar Insulin Market Size and Growth Rate of Medical Center from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biosimilar Insulin Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilar Insulin by Major Types
-
3.4.1 Market Size and Growth Rate of Rapid Acting Insulins
-
3.4.2 Market Size and Growth Rate of Short Acting Insulins
-
3.4.3 Market Size and Growth Rate of Intermediate Insulins
-
3.4.4 Market Size and Growth Rate of Long Lasting Insulins
4 Segmentation of Biosimilar Insulin Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilar Insulin by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biosimilar Insulin in Hospital
-
4.4.2 Market Size and Growth Rate of Biosimilar Insulin in Clinic
-
4.4.3 Market Size and Growth Rate of Biosimilar Insulin in Medical Center
5 Market Analysis by Regions
-
5.1 China Biosimilar Insulin Production Analysis by Regions
-
5.2 China Biosimilar Insulin Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Biosimilar Insulin Landscape Analysis
-
6.1 North China Biosimilar Insulin Landscape Analysis by Major Types
-
6.2 North China Biosimilar Insulin Landscape Analysis by Major End-Users
7 Central China Biosimilar Insulin Landscape Analysis
-
7.1 Central China Biosimilar Insulin Landscape Analysis by Major Types
-
7.2 Central China Biosimilar Insulin Landscape Analysis by Major End-Users
8 South China Biosimilar Insulin Landscape Analysis
-
8.1 South China Biosimilar Insulin Landscape Analysis by Major Types
-
8.2 South China Biosimilar Insulin Landscape Analysis by Major End-Users
9 East China Biosimilar Insulin Landscape Analysis
-
9.1 East China Biosimilar Insulin Landscape Analysis by Major Types
-
9.2 East China Biosimilar Insulin Landscape Analysis by Major End-Users
10 Northeast China Biosimilar Insulin Landscape Analysis
-
10.1 Northeast China Biosimilar Insulin Landscape Analysis by Major Types
-
10.2 Northeast China Biosimilar Insulin Landscape Analysis by Major End-Users
11 Southwest China Biosimilar Insulin Landscape Analysis
-
11.1 Southwest China Biosimilar Insulin Landscape Analysis by Major Types
-
11.2 Southwest China Biosimilar Insulin Landscape Analysis by Major End-Users
12 Northwest China Biosimilar Insulin Landscape Analysis
-
12.1 Northwest China Biosimilar Insulin Landscape Analysis by Major Types
-
12.2 Northwest China Biosimilar Insulin Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Samsung Bioepis
-
13.1.1 Samsung Bioepis Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Biogenomics
-
13.2.1 Biogenomics Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Geropharm
-
13.3.1 Geropharm Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lilly
-
13.4.1 Eli Lilly Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Gan&Lee Pharmaceuticals
-
13.5.1 Gan&Lee Pharmaceuticals Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Teva Pharmaceuticals
-
13.6.1 Teva Pharmaceuticals Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Paras Biopharmaceuticals
-
13.7.1 Paras Biopharmaceuticals Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Julphar Gulf Pharmaceutical Industries
-
13.8.1 Julphar Gulf Pharmaceutical Industries Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Sedico
-
13.9.1 Sedico Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Pfizer
-
13.10.1 Pfizer Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Wockhardt
-
13.11.1 Wockhardt Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Biosimilar Insulin Market Size and Growth Rate of Rapid Acting Insulins from 2016 to 2027
-
Figure China Biosimilar Insulin Market Size and Growth Rate of Short Acting Insulins from 2016 to 2027
-
Figure China Biosimilar Insulin Market Size and Growth Rate of Intermediate Insulins from 2016 to 2027
-
Figure China Biosimilar Insulin Market Size and Growth Rate of Long Lasting Insulins from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Biosimilar Insulin Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Biosimilar Insulin Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure China Biosimilar Insulin Market Size and Growth Rate of Medical Center from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Biosimilar Insulin Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biosimilar Insulin Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biosimilar Insulin
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilar Insulin by Different Types from 2016 to 2027
-
Table Consumption Share of Biosimilar Insulin by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Rapid Acting Insulins
-
Figure Market Size and Growth Rate of Short Acting Insulins
-
Figure Market Size and Growth Rate of Intermediate Insulins
-
Figure Market Size and Growth Rate of Long Lasting Insulins
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biosimilar Insulin by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biosimilar Insulin by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Medical Center
-
Table China Biosimilar Insulin Production by Regions
-
Table China Biosimilar Insulin Production Share by Regions
-
Figure China Biosimilar Insulin Production Share by Regions in 2016
-
Figure China Biosimilar Insulin Production Share by Regions in 2021
-
Figure China Biosimilar Insulin Production Share by Regions in 2027
-
Table China Biosimilar Insulin Consumption by Regions
-
Table China Biosimilar Insulin Consumption Share by Regions
-
Figure China Biosimilar Insulin Consumption Share by Regions in 2016
-
Figure China Biosimilar Insulin Consumption Share by Regions in 2021
-
Figure China Biosimilar Insulin Consumption Share by Regions in 2027
-
Table North China Biosimilar Insulin Consumption by Types from 2016 to 2027
-
Table North China Biosimilar Insulin Consumption Share by Types from 2016 to 2027
-
Figure North China Biosimilar Insulin Consumption Share by Types in 2016
-
Figure North China Biosimilar Insulin Consumption Share by Types in 2021
-
Figure North China Biosimilar Insulin Consumption Share by Types in 2027
-
Table North China Biosimilar Insulin Consumption by End-Users from 2016 to 2027
-
Table North China Biosimilar Insulin Consumption Share by End-Users from 2016 to 2027
-
Figure North China Biosimilar Insulin Consumption Share by End-Users in 2016
-
Figure North China Biosimilar Insulin Consumption Share by End-Users in 2021
-
Figure North China Biosimilar Insulin Consumption Share by End-Users in 2027
-
Table Central China Biosimilar Insulin Consumption by Types from 2016 to 2027
-
Table Central China Biosimilar Insulin Consumption Share by Types from 2016 to 2027
-
Figure Central China Biosimilar Insulin Consumption Share by Types in 2016
-
Figure Central China Biosimilar Insulin Consumption Share by Types in 2021
-
Figure Central China Biosimilar Insulin Consumption Share by Types in 2027
-
Table Central China Biosimilar Insulin Consumption by End-Users from 2016 to 2027
-
Table Central China Biosimilar Insulin Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Biosimilar Insulin Consumption Share by End-Users in 2016
-
Figure Central China Biosimilar Insulin Consumption Share by End-Users in 2021
-
Figure Central China Biosimilar Insulin Consumption Share by End-Users in 2027
-
Table South China Biosimilar Insulin Consumption by Types from 2016 to 2027
-
Table South China Biosimilar Insulin Consumption Share by Types from 2016 to 2027
-
Figure South China Biosimilar Insulin Consumption Share by Types in 2016
-
Figure South China Biosimilar Insulin Consumption Share by Types in 2021
-
Figure South China Biosimilar Insulin Consumption Share by Types in 2027
-
Table South China Biosimilar Insulin Consumption by End-Users from 2016 to 2027
-
Table South China Biosimilar Insulin Consumption Share by End-Users from 2016 to 2027
-
Figure South China Biosimilar Insulin Consumption Share by End-Users in 2016
-
Figure South China Biosimilar Insulin Consumption Share by End-Users in 2021
-
Figure South China Biosimilar Insulin Consumption Share by End-Users in 2027
-
Table East China Biosimilar Insulin Consumption by Types from 2016 to 2027
-
Table East China Biosimilar Insulin Consumption Share by Types from 2016 to 2027
-
Figure East China Biosimilar Insulin Consumption Share by Types in 2016
-
Figure East China Biosimilar Insulin Consumption Share by Types in 2021
-
Figure East China Biosimilar Insulin Consumption Share by Types in 2027
-
Table East China Biosimilar Insulin Consumption by End-Users from 2016 to 2027
-
Table East China Biosimilar Insulin Consumption Share by End-Users from 2016 to 2027
-
Figure East China Biosimilar Insulin Consumption Share by End-Users in 2016
-
Figure East China Biosimilar Insulin Consumption Share by End-Users in 2021
-
Figure East China Biosimilar Insulin Consumption Share by End-Users in 2027
-
Table Northeast China Biosimilar Insulin Consumption by Types from 2016 to 2027
-
Table Northeast China Biosimilar Insulin Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Biosimilar Insulin Consumption Share by Types in 2016
-
Figure Northeast China Biosimilar Insulin Consumption Share by Types in 2021
-
Figure Northeast China Biosimilar Insulin Consumption Share by Types in 2027
-
Table Northeast China Biosimilar Insulin Consumption by End-Users from 2016 to 2027
-
Table Northeast China Biosimilar Insulin Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Biosimilar Insulin Consumption Share by End-Users in 2016
-
Figure Northeast China Biosimilar Insulin Consumption Share by End-Users in 2021
-
Figure Northeast China Biosimilar Insulin Consumption Share by End-Users in 2027
-
Table Southwest China Biosimilar Insulin Consumption by Types from 2016 to 2027
-
Table Southwest China Biosimilar Insulin Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Biosimilar Insulin Consumption Share by Types in 2016
-
Figure Southwest China Biosimilar Insulin Consumption Share by Types in 2021
-
Figure Southwest China Biosimilar Insulin Consumption Share by Types in 2027
-
Table Southwest China Biosimilar Insulin Consumption by End-Users from 2016 to 2027
-
Table Southwest China Biosimilar Insulin Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Biosimilar Insulin Consumption Share by End-Users in 2016
-
Figure Southwest China Biosimilar Insulin Consumption Share by End-Users in 2021
-
Figure Southwest China Biosimilar Insulin Consumption Share by End-Users in 2027
-
Table Northwest China Biosimilar Insulin Consumption by Types from 2016 to 2027
-
Table Northwest China Biosimilar Insulin Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Biosimilar Insulin Consumption Share by Types in 2016
-
Figure Northwest China Biosimilar Insulin Consumption Share by Types in 2021
-
Figure Northwest China Biosimilar Insulin Consumption Share by Types in 2027
-
Table Northwest China Biosimilar Insulin Consumption by End-Users from 2016 to 2027
-
Table Northwest China Biosimilar Insulin Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Biosimilar Insulin Consumption Share by End-Users in 2016
-
Figure Northwest China Biosimilar Insulin Consumption Share by End-Users in 2021
-
Figure Northwest China Biosimilar Insulin Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Samsung Bioepis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Bioepis
-
Figure Sales and Growth Rate Analysis of Samsung Bioepis
-
Figure Revenue and Market Share Analysis of Samsung Bioepis
-
Table Product and Service Introduction of Samsung Bioepis
-
Table Company Profile and Development Status of Biogenomics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogenomics
-
Figure Sales and Growth Rate Analysis of Biogenomics
-
Figure Revenue and Market Share Analysis of Biogenomics
-
Table Product and Service Introduction of Biogenomics
-
Table Company Profile and Development Status of Geropharm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Geropharm
-
Figure Sales and Growth Rate Analysis of Geropharm
-
Figure Revenue and Market Share Analysis of Geropharm
-
Table Product and Service Introduction of Geropharm
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Gan&Lee Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gan&Lee Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Gan&Lee Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Gan&Lee Pharmaceuticals
-
Table Product and Service Introduction of Gan&Lee Pharmaceuticals
-
Table Company Profile and Development Status of Teva Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Teva Pharmaceuticals
-
Table Product and Service Introduction of Teva Pharmaceuticals
-
Table Company Profile and Development Status of Paras Biopharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paras Biopharmaceuticals
-
Figure Sales and Growth Rate Analysis of Paras Biopharmaceuticals
-
Figure Revenue and Market Share Analysis of Paras Biopharmaceuticals
-
Table Product and Service Introduction of Paras Biopharmaceuticals
-
Table Company Profile and Development Status of Julphar Gulf Pharmaceutical Industries
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Julphar Gulf Pharmaceutical Industries
-
Figure Sales and Growth Rate Analysis of Julphar Gulf Pharmaceutical Industries
-
Figure Revenue and Market Share Analysis of Julphar Gulf Pharmaceutical Industries
-
Table Product and Service Introduction of Julphar Gulf Pharmaceutical Industries
-
Table Company Profile and Development Status of Sedico
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sedico
-
Figure Sales and Growth Rate Analysis of Sedico
-
Figure Revenue and Market Share Analysis of Sedico
-
Table Product and Service Introduction of Sedico
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Wockhardt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wockhardt
-
Figure Sales and Growth Rate Analysis of Wockhardt
-
Figure Revenue and Market Share Analysis of Wockhardt
-
Table Product and Service Introduction of Wockhardt
-
